Clinical Trials Directory

Trials / Unknown

UnknownNCT04189250

Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol

Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol Determining Hemoglobinmass With Capillary and Venous Blood Sampling

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
31 (estimated)
Sponsor
Swiss Federal Institute of Sport Magglingen · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is the comparison of two measurement protocols determining hemoglobin mass with two different blood sampling strategies.Both protocols are based on the principle of the carbonmonoxid (CO) rebreathing method. During this measurement, CO is inhaled for a specific time period by the subject in a closed circuit and it is used as a marker to tag circulating hemoglobin.

Detailed description

The optimized CO rebreathing protocol (oCO) will be compared against the automatized CO rebreathing protocol (aCO). Although theses two protocols using the same method, they show some relevant differences. The oCO use a 2 minutes rebreathing period in a seated position and capillary blood is taken. The aCO use a 10 minutes rebreathing period in a supine position and venous blood samples are taken. It is essential to know to what extent the aCO with capillary or venous blood sampling with different rebreathing time and position compared to oCO will influence the provided hemoglobin mass values. It is important to ensure the comparability of formely hemoglobinmass data measured using oCO with hemoglobinmass data measured using aCO for scientific research.

Conditions

Interventions

TypeNameDescription
DEVICEAutomatized carbonmonoxide rebreathing machine - OpCO Detalo instrumentsThe automatized protocol (aCO) will be conducted with automated system OpCO of Detalo instruments. The intended use of the OpCO Detalo instrument is to quantify hemoglobin mass in human. The principle behind the machine is the widely used CO rebreathing technique. The machine applies automatically the desired CO dose to the patient to determine hemoglobin mass. The Detalo Instruments OpCO is certified conform to the following CE norms: Electromagentic compabilitiy: DIN EN 60601-1-2 and electrical Safety test: LVD 2014/35/EU.

Timeline

Start date
2020-01-20
Primary completion
2020-04-20
Completion
2020-08-01
First posted
2019-12-06
Last updated
2020-03-11

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04189250. Inclusion in this directory is not an endorsement.